Table 5

Additional efficacy outcomes (among evaluable patients)

OutcomeMedian (95% CI)
Time to VGPR + PR, mo 1.6 (1.6-3.5) 
PFS, mo 6.1 (3.7-9.4) 
OS, mo — (17=—) 
OutcomeMedian (95% CI)
Time to VGPR + PR, mo 1.6 (1.6-3.5) 
PFS, mo 6.1 (3.7-9.4) 
OS, mo — (17=—) 

VGPR indicates very good partial remission; PR, partial remission; PFS, progression free survival; OS, overall survival; and —, not reached yet.

View Large